| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11025547 | Neurobiology of Disease | 2019 | 36 Pages |
Abstract
These findings are relevant as they confirm the 5AR enzyme as a potential therapeutic target for treatment of dyskinesia in PD, suggesting the first ever evidence that neurosteroidogenesis may affect functional interaction between dopamine D1R and D3R.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Silvia Fanni, Simona Scheggi, Francesca Rossi, Elisabetta Tronci, Francesco Traccis, Roberto Stancampiano, Maria Graziella De Montis, Paola Devoto, Carla Gambarana, Marco Bortolato, Roberto Frau, Manolo Carta,